Zulmarie Franco

National Institutes of Health — United States

Medicine · Health Sciences

11h-index699citations37works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(26), Cancer Immunotherapy and Biomarkers(21), Immunotherapy and Immune Responses(15), Immune Cell Function and Interaction(7), Cytokine Signaling Pathways and Interactions(5)

Publications37 total

PTEN mutation status in uterine carcinosarcomas: A comprehensive overview and a new diagnostic approach
Pathology - Research and Practice·2025
Exploring Innovative Approaches to Hematopoietic Progenitor Cell Selection Using Automated Methods
Cytotherapy·2025
Immunotherapy: UNMET NEED: DEVELOPING TCR-T CELL THERAPIES FOR HIV PATIENTS WITH HPV-ASSOCIATED CANCERS
Cytotherapy·2023
Supplementary Figures 1 - 12 and Tables 1 - 11 from Type I Cytokines Synergize with Oncogene Inhibition to Induce Tumor Growth Arrest
2023Open Access
Supplementary Materials and Methods from Type I Cytokines Synergize with Oncogene Inhibition to Induce Tumor Growth Arrest
2023Open Access
Data from Type I Cytokines Synergize with Oncogene Inhibition to Induce Tumor Growth Arrest
2023Open Access
Data from Type I Cytokines Synergize with Oncogene Inhibition to Induce Tumor Growth Arrest
2023Open Access
Supplementary Figures 1 - 12 and Tables 1 - 11 from Type I Cytokines Synergize with Oncogene Inhibition to Induce Tumor Growth Arrest
2023Open Access
Supplementary Materials and Methods from Type I Cytokines Synergize with Oncogene Inhibition to Induce Tumor Growth Arrest
2023Open Access
Table S3 from Impact of Prior Treatment on the Efficacy of Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma
2023Open Access
Data from Impact of Prior Treatment on the Efficacy of Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma
2023Open Access
Figure S1 from Impact of Prior Treatment on the Efficacy of Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma
2023Open Access
Table S3 from Impact of Prior Treatment on the Efficacy of Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma
2023Open Access
Table S2 from Impact of Prior Treatment on the Efficacy of Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma
2023Open Access
Table S2 from Impact of Prior Treatment on the Efficacy of Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma
2023Open Access
Table S1 from Impact of Prior Treatment on the Efficacy of Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma
2023Open Access
Figure S1 from Impact of Prior Treatment on the Efficacy of Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma
2023Open Access
Data from Impact of Prior Treatment on the Efficacy of Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma
2023Open Access
Figure S2 from Impact of Prior Treatment on the Efficacy of Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma
2023Open Access
Table S1 from Impact of Prior Treatment on the Efficacy of Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma
2023Open Access
page 1 of 2Next →

Frequent Co-authors

Steven A. Rosenberg(20), Douglas C. Palmer(17), Nicholas P. Restifo(17), Thomas E. Shelton(14), Michelle M. Langhan(14), David N. Danforth(14), Samantha J. Seitter(13), Richard M. Sherry(13), Mackenzie L. Shindorf(13), Amy R. Copeland(13), Christine T. McGowan(13), Stephanie L. Goff(13), James C. Yang(13), Monica Epstein(12), Rahul Roychoudhuri(11), Paul F. Robbins(11), Christopher A. Klebanoff(10), Madhusudhanan Sukumar(10), David Clever(10), Luca Gattinoni(10)